Pharmacoeconomic analysis of Cocarnit® complex as treatment for diabetic polyneuropathy

Pharmacoeconomic analysis of Cocarnit® complex as treatment for diabetic polyneuropathy

Diabetic polyneuropathy (DP) occupies the third place among the most common neurological disorders, affecting a significant portion of diabetes patients, and is characterized by progressive lesions of nervous fibers. While normalizing carbohydrate metabolism is crucial for treating DP, metabolic com...

Full description

Bibliographic Details
Main Authors: D. Yu. Belousov, A. E. Cheberda
Format: Article
Language:Russian
Published: Izdatelstvo OKI 2018-05-01
Series:Качественная клиническая практика
Subjects:
сахарный диабет
кокарнит
мильгамма
фармакоэкономика
нейропатия
полинейропатия
анализ полезности затрат
анализ минимизации затрат
анализ влияния на бюджет
diabetes mellitus
cocarnit
milgamma
pharmacoeconomics
cost-utility analysis
cost minimization analysis
budget impact analysis
neuropathy
polyneuropathy
Online Access:https://www.clinvest.ru/jour/article/view/63

Internet

https://www.clinvest.ru/jour/article/view/63

Similar Items